![AstraZeneca – Integrating human and environmental health in antibiotic risk assessment](https://www.amrindustryalliance.org/wp-content/uploads/2017/11/431727_1_690x459.87020316027.jpg)
![AstraZeneca – Integrating human and environmental health in antibiotic risk assessment](https://www.amrindustryalliance.org/wp-content/uploads/2017/11/431727_1_690x459.87020316027.jpg)
![BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-738786269-1080x675.jpg)
BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.
![CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-130404655-1080x675.jpg)
CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant
![Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-561094027-1080x675.jpg)
Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration
![BD – Phoenix™ M50 System](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-637785818-1080x675.jpg)